Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant ; volume:4 ; number:1 ; day:23 ; month:10 ; year:2006 ; pages:1-12 ; date:6.2006
Journal of translational medicine ; 4, Heft 1 (23.10.2006), 1-12, 6.2006
- Urheber
-
Koh, Yi T.
- Beteiligte Personen und Organisationen
-
Higgins, Sean A.
Weber, Jeffrey S.
Kast, W Martin
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-4-42
- URN
-
urn:nbn:de:1111-2016041431251
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koh, Yi T.
- Higgins, Sean A.
- Weber, Jeffrey S.
- Kast, W Martin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adjuvants for peptide-based cancer vaccines
Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines
Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation
Peptide-based materials
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Clinical and immunological effects of mRNA vaccines in malignant diseases
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Peptide-based vectors: recent developments
Incomplete immunological reconstitution of nai͏̈ve Tcellcompartmentafter antiretroviral treatment (ART) in HIV-1 infection
Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule
DNA aptamer-based rolling circle amplification product as a novel immunological adjuvant
Adjuvants for peptide-based cancer vaccines
Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines
Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation
Peptide-based materials
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Clinical and immunological effects of mRNA vaccines in malignant diseases
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Peptide-based vectors: recent developments
Incomplete immunological reconstitution of nai͏̈ve Tcellcompartmentafter antiretroviral treatment (ART) in HIV-1 infection
Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule
DNA aptamer-based rolling circle amplification product as a novel immunological adjuvant
Adjuvants for peptide-based cancer vaccines
Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines
Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation
Peptide-based materials
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Clinical and immunological effects of mRNA vaccines in malignant diseases
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Peptide-based vectors: recent developments
Incomplete immunological reconstitution of nai͏̈ve Tcellcompartmentafter antiretroviral treatment (ART) in HIV-1 infection
Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule